ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)

被引：0
|
作者：
Susanna Slater
Annette Bryant
Hsiang-Chi Chen
Ruwaida Begum
Isma Rana
Maria Aresu
Clare Peckitt
Oleg Zhitkov
Retchel Lazaro-Alcausi
Victoria Borja
Rachel Powell
David Lowery
Michael Hubank
Thereasa Rich
Gayathri Anandappa
Ian Chau
Naureen Starling
David Cunningham
机构：
[1] Royal Marsden Hospital NHS Foundation Trust,
[2] Biomedical Research Centre at the Royal Marsden and the Institute of Cancer Research,undefined
[3] Centre for Molecular Pathology at the The Royal Marsden Hospital and Institute of Cancer Research,undefined
[4] Guardant Health,undefined
[5] INC,undefined
来源：
BMC Cancer | / 23卷
关键词：
Colorectal cancer; ctDNA; Adjuvant chemotherapy; Randomised; Disease free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C)
    Slater, Susanna
    Bryant, Annette
    Chen, Hsiang-Chi
    Begum, Ruwaida
    Rana, Isma
    Aresu, Maria
    Peckitt, Clare
    Zhitkov, Oleg
    Lazaro-Alcausi, Retchel
    Borja, Victoria
    Powell, Rachel
    Lowery, David
    Hubank, Michael
    Rich, Thereasa
    Anandappa, Gayathri
    Chau, Ian
    Starling, Naureen
    Cunningham, David
    BMC CANCER, 2023, 23 (01)
  • [2] TRACC: Tracking mutations in cell-free DNA to predict relapse in early colorectal cancer-A randomized study of circulating tumour DNA (ctDNA) guided adjuvant chemotherapy versus standard of care chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer (CRC).
    Anandappa, Gayathri
    Starling, Naureen
    Peckitt, Clare
    Bryant, Annette
    Begum, Ruwaida
    Carter, Paul
    Hatt, Shelby
    Khakoo, Shelize Sadrudin
    Turner, Andrea
    Kidd, Shannon
    Duncan, Julie
    Hobbis, Laura
    Giorgakoudi, Kyriaki
    Smalley, Michaela
    Lowery, David
    Wheatstone, Pete
    Chau, Ian
    Hubank, Michael
    Cunningham, David
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Adjuvant chemoradiation versus chemotherapy for stage III gastric cancer after surgery with curative intent
    Turanli, Sevim
    Atalay, Can
    Berberoglu, Ugur
    Gulben, Kaptan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (02) : 369 - 374
  • [4] The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients
    Kosuke Mima
    Nobutomo Miyanari
    Keisuke Kosumi
    Takuya Tajiri
    Kosuke Kanemitsu
    Toru Takematsu
    Mitsuhiro Inoue
    Takao Mizumoto
    Tatsuo Kubota
    Hideo Baba
    International Journal of Clinical Oncology, 2021, 26 : 903 - 912
  • [5] The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients
    Mima, Kosuke
    Miyanari, Nobutomo
    Kosumi, Keisuke
    Tajiri, Takuya
    Kanemitsu, Kosuke
    Takematsu, Toru
    Inoue, Mitsuhiro
    Mizumoto, Takao
    Kubota, Tatsuo
    Baba, Hideo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (05) : 903 - 912
  • [6] Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer:: a multicentre randomised controlled phase III trial
    Nordlinger, B
    Rougier, P
    Arnaud, JP
    Debois, M
    Wils, J
    Ollier, JC
    Grobost, O
    Lasser, P
    Wals, J
    Lacourt, J
    Seitz, JF
    dos Santos, JG
    Bleiberg, H
    Mackiewickz, R
    Conroy, T
    Bouché, O
    Morin, T
    Baila, L
    van Cutsem, E
    Bedenne, L
    LANCET ONCOLOGY, 2005, 6 (07): : 459 - 468
  • [7] Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
    Lee, Yujin
    Park, Inseok
    Cho, Hyunjin
    Gwak, Geumhee
    Yang, Keunho
    Bae, Byung-Noe
    ANNALS OF COLOPROCTOLOGY, 2021, 37 (05) : 298 - 305
  • [8] A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
    Schippinger, W.
    Samonigg, H.
    Schaberl-Moser, R.
    Greil, R.
    Thoedtmann, R.
    Tschmelitsch, J.
    Jagoditsch, M.
    Steger, G. G.
    Jakesz, R.
    Herbst, F.
    Hofbauer, F.
    Rabl, H.
    Wohlmuth, P.
    Gnant, M.
    Thaler, J.
    BRITISH JOURNAL OF CANCER, 2007, 97 (08) : 1021 - 1027
  • [9] A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
    W Schippinger
    H Samonigg
    R Schaberl-Moser
    R Greil
    R Thödtmann
    J Tschmelitsch
    M Jagoditsch
    G G Steger
    R Jakesz
    F Herbst
    F Hofbauer
    H Rabl
    P Wohlmuth
    M Gnant
    J Thaler
    British Journal of Cancer, 2007, 97 : 1021 - 1027
  • [10] Survival paradox and effect of adjuvant chemotherapy for high-risk Stage II and low-risk Stage III colorectal cancer
    Noda, Keisuke
    Tominaga, Tetsuro
    Nonaka, Takashi
    Ono, Rika
    Oishi, Kaido
    Takamura, Yuma
    Shiraishi, Toshio
    Hashimoto, Shintaro
    Hisanaga, Makoto
    Takeshita, Hiroaki
    Ishii, Mitsutoshi
    Oyama, Shosaburo
    Ishimaru, Kazuhide
    Sawai, Terumitsu
    Matsumoto, Keitaro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025,
12345